Vimarsana
Biggest News Aggregation in the World

Page 2 - Hookipa Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hookipa Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hookipa Pharma Today - Breaking & Trending Today

Eight biotech companies you should know about in Austria - Vimarsana News

Eight biotech companies you should know about in Austria

Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward.

Q1 2024 EPS Estimates for Hookipa Pharma Inc Lifted by Analyst (NASDAQ:HOOK) - Vimarsana News

Q1 2024 EPS Estimates for Hookipa Pharma Inc Lifted by Analyst (NASDAQ:HOOK)

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) – Research analysts at HC Wainwright boosted their Q1 2024 earnings per share (EPS) estimates for shares of Hookipa Pharma in a research report issued on Monday, March 25th. HC Wainwright analyst A. He now forecasts that the company will earn ($0.18) per share for the quarter, up […]

Brokers Set Expectations for Hookipa Pharma Inc's FY2028 Earnings (NASDAQ:HOOK) - Vimarsana News

Brokers Set Expectations for Hookipa Pharma Inc's FY2028 Earnings (NASDAQ:HOOK)

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) – Equities researchers at HC Wainwright issued their FY2028 earnings per share estimates for shares of Hookipa Pharma in a report released on Monday, March 25th. HC Wainwright analyst A. He forecasts that the company will post earnings of $0.31 per share for the year. HC Wainwright currently […]

Hookipa Pharma's (HOOK) "Outperform" Rating Reaffirmed at Royal Bank of Canada - Vimarsana News

Hookipa Pharma's (HOOK) "Outperform" Rating Reaffirmed at Royal Bank of Canada

Hookipa Pharma (NASDAQ:HOOK – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a research report issued on Monday, Benzinga reports. They currently have a $5.00 price target on the stock. Separately, HC Wainwright restated a “buy” rating and issued a $6.50 price objective on shares […]

Hookipa Pharma (NASDAQ:HOOK) Receives "Outperform" Rating from Royal Bank of Canada - Vimarsana News

Hookipa Pharma (NASDAQ:HOOK) Receives "Outperform" Rating from Royal Bank of Canada

Hookipa Pharma (NASDAQ:HOOK – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a note issued to investors on Monday, Benzinga reports. They currently have a $5.00 price objective on the stock. Separately, HC Wainwright reissued a “buy” rating and set a $6.50 price target on […]

Source: wkrb13.com